ClinicalTrials.Veeva

Menu

Prevention of Capecitabine Induced Hand and Foot Syndrome

Clalit Health Services logo

Clalit Health Services

Status

Unknown

Conditions

Cancer

Treatments

Device: socks containing copper-oxide fibers

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Capecitabine is a common anti cancer drug. One of the most common side effects is a syndrome called hand and foot syndrome which comprises of hands and feet redness, swelling, dryness and painful sores. Quite often the drug dose is reduced to suboptimal level due to this side effect. There is no way to prevent or an effective way to treat this side effect. The investigators aim is to investigate whether wearing socks which contain copper fibers may prevent or alleviate the patient symptoms.

Full description

Capecitabine is a common anti cancer drug. One of the most common side effects is a syndrome called hand and foot syndrome which comprises of hands and feet redness, swelling, dryness and painful sores. Quite often the drug dose is reduced to suboptimal level due to this side effect. There is no way to prevent or an effective way to treat this side effect. Our aim is to investigate whether wearing socks which contain copper fibers may prevent or alleviate the patient symptoms.

The patients will use socks containing copper-oxide impregnated fibers which are sold in the Pharma stores without physician's prescription.(EPA numbers 8454-2, 8454-3 from April 30 2009).

Drug Toxicity and skin reaction will be documented.

Enrollment

10 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of stage IV cancer - treated with Capecitabine

Exclusion criteria

  • Any patient who can not sign an informed consent
  • Pregnant women

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

socks containing copper-oxide fibers
Experimental group
Treatment:
Device: socks containing copper-oxide fibers

Trial contacts and locations

1

Loading...

Central trial contact

Rinat Yerusahlmi, MD; Aaron Sulkes, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems